MegaPro Biomedical Co., Ltd

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

www.megaprobio.com

Country

Taiwan

Exchange

Taipei Exchange

Founded 2014

MegaPro Biomedical Co., Ltd, a biotech company develops nano drugs. It also develops MPB-1523, an IOP injection that is in Phase II clinical trial for use in the treatment of hepatocellular carcinoma

MPB-1514, an iron injection that is in Phase II clinical trial for use in the treatment of iron deficiency anemia MPB-1734, an anti-cancer drug that is in preclinical trial for the treatment of malignant tumor. Founded in 2014, the company is based in Zhubei, Taiwan.

Key Stats

52-Week Range

NT$9.50NT$20.10

BetaN/A

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-1.81

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.